Share Twitter LinkedIn Facebook Email Kirsten Timms, Ph.D., VP Biomarker Discovery at Myriad Genetics Inc speaks about SABCS 2021 Abstract – P5-13-09 Identifying homologous recombination deficiency in breast cancer: Genomic instability score thresholds differ in breast cancer subtypes.
2025 Breast Cancer Updates: Dr. Evanthia Roussos Torres on Biomarkers, Immunotherapy, and the Future of Treatment – MOASC Breast 6 Mins Read
FDA Approves Datopotamab Deruxtecan / Datroway from Eli Lilly in Treatment for Unresectable or Metastatic HR-Positive, HER2-Negative Breast Cancer Breast 2 Mins Read